Hans Tanner
Director/Board Member presso PAION AG
Patrimonio netto: 308 555 $ in data 31/03/2024
Profilo
Hans Christoph Tanner is the founder of A&A Active Investor AG, 20 Minuten-Holding AG, and 20 Minuten AG.
He is currently an Independent Non-Executive Director at DKSH Holding AG since 2012, a Director at Cosmo Holding SpA since 2005, a Director at Cosmo Bioscience, Inc., a Director at Qvanteq AG since 2010, a Director at FARa Holz AG, a Director at Wyss Zurich, a Director at Lifematrix Technologies AG, a Member-Supervisory Board at PAION AG since 2017, and a Member-Supervisory Board at CureVac SE since 2015.
He previously served as an Independent Non-Executive Director at Private Equity Holding AG from 2006 to 2018, a Director at Hugin AS, a Director at Joimax GmbH, a Non-Executive Director at Cosmo Pharmaceuticals NV from 2006 to 2021, the Head of Corporate Finance & Capital Markets at UBS AG from 1992 to 1998, the Chief Financial Officer at Cosmo Pharmaceuticals SA from 2006 to 2010, a Partner at Ernst Mueller Moehl from 1998 to 2001, the Head of Corporate Banking at UBS South Africa (Pty) Ltd.
from 1987 to 1992, the Chief Financial Officer at Cassiopea SpA from 2015 to 2020, the Head of Corporate Banking at UBS Australia Pty Ltd.
from 1987 to 1992, and a Member-Supervisory Board at CureVac NV from 2015 to 2023.
He obtained his undergraduate and doctorate degrees from the University of St. Gallen.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CUREVAC N.V.
0.03% | 31/03/2023 | 75 622 ( 0.03% ) | 229 135 $ | 31/03/2024 |
DKSH HOLDING AG
0.00% | 31/12/2022 | 1 166 ( 0.00% ) | 79 421 $ | 31/03/2024 |
Posizioni attive di Hans Tanner
Società | Posizione | Inizio |
---|---|---|
DKSH HOLDING AG | Director/Board Member | 01/01/2011 |
PAION AG | Director/Board Member | 01/06/2017 |
Lifematrix Technologies AG
Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert. | Director/Board Member | - |
Wyss Zurich
Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Director/Board Member | - |
FARa Holz AG
FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Director/Board Member | - |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Director/Board Member | 01/01/2015 |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Director/Board Member | 01/01/2005 |
Qvanteq AG
Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Director/Board Member | 01/01/2010 |
Cosmo Bioscience, Inc. | Director/Board Member | 28/04/2010 |
Precedenti posizioni note di Hans Tanner
Società | Posizione | Fine |
---|---|---|
░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Formazione di Hans Tanner
University of St. Gallen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
PAION AG | Health Technology |
DKSH HOLDING AG | Distribution Services |
COSMO PHARMACEUTICALS N.V. | Health Technology |
CUREVAC N.V. | Health Technology |
Aziende private | 19 |
---|---|
UBS AG
UBS AG Investment ManagersFinance UBS AG engages in the provision of financial advisory solutions for private and institutional investors, intermediaries, and wealth management clients. The firm focuses on the areas of wealth and asset management, as well as investment banking. It offers retail investment products, global financing services, investment research, bespoke financing, traditional investments, as well as bonds and equities. The company was founded in 1862 and is headquartered in Zurich, Switzerland. | Finance |
Private Equity Holding AG
Private Equity Holding AG Investment ManagersFinance Private Equity Holding AG, a fund of funds, invests in US and Israel private equity funds. It also makes secondary direct investments. | Finance |
Cosmo Pharmaceuticals SA
Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Cosmo Pharmaceuticals SA operates as a pharmaceutical company that engages in the manufacturing of pharmaceutical drugs. It focuses on the development of gastro-intestinal pharmaceutical products for the treatment of inflammatory bowel diseases, colon infections and colon diagnosis, and treated skin disorders. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Lainate, Italy. | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
20 Minuten-Holding AG
20 Minuten-Holding AG Publishing: NewspapersConsumer Services Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002. | Consumer Services |
Ernst Mueller Moehl
Ernst Mueller Moehl Investment Banks/BrokersFinance Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland. | Finance |
A&A Active Investor AG | Finance |
20 Minuten AG
20 Minuten AG Publishing: NewspapersConsumer Services 20 Minuten AG publishes newspapers and provides online information services. It also provides French-language edition 20 minutes for the French-speaking agglomerations of Geneva and Lausanne. In France, the identically named 20 minutes editions are published by Schibsted and Ouest-France. The company is headquartered in Zurich, Switzerland. | Consumer Services |
Hugin AS
Hugin AS Internet Software/ServicesTechnology Services Hugin AS provides communication and distribution services. The firm distributes press releases on behalf of over 630 companies throughout Europe in 9 countries such as Belgium, Denmark, Finland, Germany, Norway, and the UK. It also offers investors and journalists its real time news through its internet portal at www.huginonline.com and via free subscription as an email alert service. The company was founded in 1995 and is headquartered in Oslo, Norway. | Technology Services |
UBS South Africa (Pty) Ltd.
UBS South Africa (Pty) Ltd. Investment Banks/BrokersFinance UBS South Africa (Pty) Ltd. (UBSSA) is the broker subsidiary of UBS AG, which is ultimately held by UBS Group AG (NYSE: UBS). The firm is headquartered in Johannesburg. UBSSA provides brokerage services to private, institutional and corporate clients. | Finance |
Cassiopea SpA
Cassiopea SpA Pharmaceuticals: MajorHealth Technology Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The firm's products include Winlevi, Breezula, Clascoterone Solution, CB-06-02, and CB-06-01. The company was founded on July 30, 2013 and is headquartered in Milan, Italy. | Health Technology |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Health Technology |
Cosmo Bioscience, Inc. | |
Joimax GmbH
Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Health Technology |
UBS Australia Pty Ltd.
UBS Australia Pty Ltd. Investment ManagersFinance Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The private company is based in Sydney, Australia. The CEO of the company is Matthew Grounds. | Finance |
Qvanteq AG
Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Health Technology |
FARa Holz AG
FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Non-Energy Minerals |
Wyss Zurich
Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Finance |
Lifematrix Technologies AG
Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert. | Commercial Services |
- Borsa valori
- Insiders
- Hans Tanner